Methods of treating type I hypersensitivity using monophosphoryl

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4242751, 4242831, 4242821, 4242341, 4242571, 4241971, 424422, 424418, 424182, 424177, 424195, 424400, 424450, 424 7013, 514 54, 514960, 514 2, 530329, 536 5, 536124, A61K 3935, A61K 4500, A61K 3902

Patent

active

057629439

ABSTRACT:
Methods and compositions for treating type I immunoglobin E (IgE)-dependent hypersensitivity by the administration of monophosphoryl lipid A (MLA) or 3-deacylated monophosphoryl lipid A (3D-MLA) are disclosed. MLA or 3D-MLA administered alone or in combination with an allergen to a patient suffering from type I hypersensitivity reduces levels of total or allergen specific IgE and increases levels of IgG antibody in that patient. MLA and 3D-MLA can be administered as part of a desensitization regimen or as a component of a prophylactic vaccine to prevent a type I hypersensitivity reaction.

REFERENCES:
patent: 4432969 (1984-02-01), Batchelor
patent: 4436727 (1984-03-01), Ribi
patent: 4844894 (1989-07-01), Ribi
patent: 4912094 (1990-03-01), Myers et al.
patent: 4990336 (1991-02-01), Silvestri et al.
patent: 5013555 (1991-05-01), Collins
patent: 5073628 (1991-12-01), Matsuhashi et al.
patent: 5244663 (1993-09-01), Bruttmann et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating type I hypersensitivity using monophosphoryl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating type I hypersensitivity using monophosphoryl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating type I hypersensitivity using monophosphoryl will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2195968

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.